Advertisement

Host Protection by the Antibody-Forming System in Malignancy

  • T. Juhani Linna
  • Cheng-po Hu
  • Kenneth M. Lam

Abstract

We have previously reported, that not only impairment of cell-mediated immunity, but also impairment of bursa dependent, anti-body-producing capacity decreases host defense to tumors induced by the avian reticuloendotheliosis (RE) virus, strain T, indicating that both parts of the immune system have a host-protective function in this malignancy(1, 2). In order to study whether the antibody-forming system may have a host-protective function in oncogenesis in general, unrelated tumors were studied with regard to tumor development in bursectomized and control animals. The tumors chosen for this purpose were tumors induced by XC cells, a Rous sarcoma-derived tumor line, and a chemical carcinogen-induced transplantable fibrosarcoma. The three malignancies chosen for study are of widely different genesis, and convergent results could therefore illustrate a common principle in host defense in oncogenesis.

Keywords

Immune Serum Control Bird Tumor Frequency Tumor Cure Host Protection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thompson, K. D. and T. J. Linna. Nature, New Biol. 245:10–12, 1973.Google Scholar
  2. 2.
    Linna, T. J., C. Hu and K. D. Thompson. J. Natl. Cancer Inst. 53:847–854, 1974.Google Scholar
  3. 3.
    Peterson, R. D. A., B. R. Burmester, T. N. Frederickson, H. G. Purchase and R. A. Good. J. Natl. Cancer Inst. 32:1343–1354, 1964.PubMedGoogle Scholar
  4. 4.
    Linna, T. J. and C. Hu. Rad. Res. (in press), 1975.Google Scholar
  5. 5.
    Linna, T. J., C. Hu and K. D. Thompson. In Virus Tumorigenesis and Immunogenesis, pp. 141–165. Academic Press, New York London, 1973.Google Scholar
  6. 6.
    McArthur, W. P., E. A. Carswell, and G. J. Thorbecke, J. Natl. Cancer Inst., 49:907–909, 1972.PubMedGoogle Scholar
  7. 7.
    Radzichovskaja, R. Nature, 213:1259–1260, 1967.CrossRefGoogle Scholar
  8. 8.
    Svoboda, J. Folia Biol. (Praha), 7:46–70, 1961.Google Scholar
  9. 9.
    Svoboda, J., P. Chyle, D. Simkovic, and I. Hilgert. Fol. Biol. (Praha), 9:77–81, 1963.Google Scholar
  10. 10.
    Lam, K. M., and T. J. Linna. Fed. Proc., 34:963, 1975.Google Scholar
  11. 11.
    Linna, T. J., D. Frommel and R. A. Good. Int. Arch. Allergy 42:20–39, 1972.PubMedCrossRefGoogle Scholar
  12. 12.
    Smith, R. T. and M. Landy (eds.): Immune Surveillance. New York, Academic Press Inc., 1970.Google Scholar
  13. 13.
    Evans, R., H. Cox and P. Alexander. Proc. Soc. Exp. Biol. Med. 143:256–259, 1973.PubMedGoogle Scholar
  14. 14.
    Gorer, P.A. Ann. N. Y. Acad. Sci. 73:707–721, 1958.Google Scholar
  15. 15.
    Hersey, P. Br. J. Cancer 28 (Suppl. I):11–18, 1973.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • T. Juhani Linna
    • 1
  • Cheng-po Hu
    • 1
  • Kenneth M. Lam
    • 1
  1. 1.Department of Microbiology and ImmunologyTemple University School of MedicinePhiladelphiaUSA

Personalised recommendations